Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.65
0.00 (0.03%)
At close: Aug 15, 2025, 3:59 PM
0.67
2.31%
After-hours: Aug 15, 2025, 07:58 PM EDT

Adicet Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 6.51M n/a n/a n/a 12.89M n/a n/a n/a -24.99M n/a n/a 24.99M 5.47M 3.43M 4.81M -3.98M
Cost of Revenue
1.6M 1.68M n/a 1.59M 1.6M 1.65M 1.69M 2.35M 2.28M 1.81M 1.78M 1.17M 1.06M 997K -552K n/a n/a n/a
Gross Profit
-1.6M -1.68M 3.25M -1.59M -1.6M -1.65M 11.21M -2.35M -2.28M -1.81M -26.77M -1.17M -1.06M 23.99M 6.02M 3.43M 4.81M -3.98M
Operating Income
-32.39M -29.89M -30.74M -33.15M -32.85M -30.87M -31.57M -52.26M -34.89M -33.32M -31.57M -22.98M -22.71M 4.71M -15.54M -13.71M -10.83M -21.35M
Interest Income
1.4M 1.68M 2.07M 2.73M 3M 2.92M 2.18M 2.52M 2.62M 2.67M 2.18M 1.22M 325K 32K 37K 4K 9K 41K
Pretax Income
-31.22M -28.21M -28.73M -30.48M -29.9M -28.02M -29.49M -49.88M -32.4M -30.88M -29.88M -22M -22.54M 4.62M -15.82M -14M -10.93M -21.37M
Net Income
-31.22M -28.21M -28.73M -30.48M -29.9M -28.02M -29.49M -49.88M -32.4M -29.63M -28.1M -21.01M -22.37M 4.62M -15.81M -14.01M -10.85M -21.32M
Selling & General & Admin
3.97M 7.07M 7.47M 6.9M 6.95M 5.32M 5.12M 6.63M 6.53M 6.57M 6.55M 6.42M 6.53M 6.8M 6.35M 5.21M 5.03M 5.63M
Research & Development
28.42M 22.81M 23.27M 26.25M 25.9M 23.9M 24.76M 26.17M 28.36M 26.76M 25.02M 16.57M 16.18M 13.48M 14.66M 11.93M 10.62M 11.74M
Other Expenses
n/a n/a n/a n/a n/a n/a 1.69M 19.46M -124K -206K -463K -217K -138K 65K -294K n/a -62K -4K
Operating Expenses
32.39M 29.89M 30.74M 33.15M 32.85M 29.22M 31.57M 52.26M 34.89M 33.32M 31.57M 22.98M 22.71M 20.35M 21.01M 17.14M 15.64M 17.37M
Interest Expense
n/a n/a 1K 1K n/a 2K n/a 1K 4K 19K 26K 18K 18K 18K 25K 50K 51K 50K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -1.65M -1.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
32.39M 29.89M 30.74M 33.15M 32.85M 30.87M 31.57M 52.26M 34.89M 33.32M 31.57M 22.98M 22.71M 20.35M 21.01M 17.14M 15.64M 17.37M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -141K -120K -1.25M -1.77M -989K -169K n/a -11K 11K -77K -48K
Shares Outstanding (Basic)
91.09M 91.07M 87.87M 90.85M 90.63M 79.07M 43.04M 42.98M 42.96M 42.89M 41.65M 41.64M 40.08M 46.18M 33.91M 31.88M 31.82M 26M
Shares Outstanding (Diluted)
91.09M 91.07M 87.87M 90.85M 90.63M 79.07M 43.04M 42.98M 42.96M 42.96M 41.65M 41.64M 40.08M 45.96M 33.91M 31.88M 31.82M 26.1M
EPS (Basic)
-0.34 -0.31 -0.32 -0.34 -0.33 -0.35 -0.69 -1.16 -0.75 -0.69 -0.67 -0.5 -0.56 0.12 -0.47 -0.44 -0.34 -0.82
EPS (Diluted)
-0.34 -0.31 -0.32 -0.34 -0.33 -0.35 -0.69 -1.16 -0.75 -0.69 -0.67 -0.5 -0.56 0.10 -0.47 -0.44 -0.34 -0.82
EBITDA
-32.39M -29.89M -27.1M -28.89M -28.3M -26.36M -27.8M -47.54M -30.11M -29.05M -28.07M -20.81M -21.46M 5.63M -15.11M -13.56M -10.42M -20.99M
EBIT
-31.22M -28.21M -28.73M -30.48M -29.9M -28.01M -29.49M -49.88M -32.4M -30.86M -29.85M -21.98M -22.52M 4.64M -15.8M -13.95M -10.88M -21.32M
Depreciation & Amortization
n/a 1.68M 1.62M 1.59M 1.6M 1.65M 1.69M 2.35M 2.28M 1.81M 1.78M 1.17M 1.06M 997K 693K 1.21M 1.15M 1.01M